Surging 20% to the daily limit! The Q1 earnings season kicks off in China’s A-share market, with 12 listed companies forecasting net profit growth of over 200% year-on-year.

①The Q1 earnings season for A-shares is gradually unfolding. The day after the earnings forecast disclosure, Fuxiang Pharmaceuticals and Bohui Shares surged by 20%, while Wanbangde, Tianshan Aluminum, and Shandong Hedao also hit their daily trading limit. ②Below is a list of A-share listed companies expected to report over 200% year-over-year growth in net profit for Q1 2026, along with reasons for performance changes (see attached table).

Cailian Press reported on April 5 (Editor Pingfang) that the Q1 earnings season is gradually unfolding. The day after the earnings forecast disclosure, Fuxiang Pharmaceuticals and Bohui Shares surged by 20%, while Wanbangde, Tianshan Aluminum, and Shandong Hedao hit their daily trading limit. Additionally, Oukeyi rose over 19%, and Dinglong Shares climbed more than 17%.

According to incomplete statistics from Cailian Press as of press time, a total of 36 A-share listed companies have released their Q1 2026 earnings forecasts. Among them, the upper limit of year-over-year net profit growth for 12 stocks exceeds 200%, including Fuxiang Pharmaceuticals, Oukeyi, Wanbangde, Qiangyi Shares, Xinrui Shares, Huarui Precision, Dongyue Silicon Materials, Shengtun Mining, Fullswell, Kuncai Technology, Aolaid Group, and Huaxin Building Materials (specific details are shown in the chart below). Furthermore, Demingli, Bohui Shares, and Weili are expected to turn profitable in Q1.

In terms of individual stocks, Fuxiang Pharmaceuticals ranks first with an estimated performance growth rate exceeding 32 times. It expects its net profit attributable to shareholders for Q1 to be between RMB 52 million and RMB 75 million, representing a year-over-year increase of 2,222.67% to 3,250.01%. Based on this calculation, the Q1 net profit is projected to grow by 437%-674% quarter-over-quarter. On the day following the earnings forecast release, its stock price surged by 20%. The company stated that it benefited from the continuous improvement in the new energy sector’s prosperity, steady growth in power battery market demand, and rapid surges in energy storage battery market demand, driving up the demand for upstream lithium battery materials. The company’s lithium battery electrolyte additive business performed well, with core products like VC and FEC achieving both higher volumes and prices, thereby significantly boosting year-over-year performance growth.

Oukeyi follows closely behind with a maximum performance growth rate of over 27 times. It expects its net profit attributable to shareholders for Q1 to be between RMB 180 million and RMB 220 million, increasing by RMB 172 million to RMB 212 million compared to the same period last year. Based on these figures, its Q1 net profit is expected to grow by approximately 2,249%-2,771% year-over-year and around 242%-318% quarter-over-quarter. Following the earnings forecast release, Oukeyi’s stock price rose over 19%. The company noted that during the reporting period, the main raw material tungsten carbide used in cemented carbide tools saw significant price increases. The company achieved both higher volumes and prices for its products. The capacity utilization rates of its CNC inserts and CNC tool industrial park projects continued to rise, accompanied by corresponding price hikes, resulting in improved gross margin and net profit margin year-over-year, which enhanced the company’s profitability.

Wanbangde ranks third with a performance growth rate exceeding nine times. It expects its net profit attributable to shareholders for Q1 to be RMB 165 million, representing a year-over-year increase of 985.4%. The day after the earnings forecast release, its stock price hit the daily trading limit. Extending the timeline, Wanbangde’s stock price has risen by a cumulative maximum of 114% since the low point in March. Regarding the reasons for performance changes, Wanbangde stated that its strategic transformation from generic drugs to innovative drugs has initially shown results, with positive progress in business expansion and continuous increased investment in research and development. At the same time, it strengthened internal management, expedited accounts receivable recovery, and effectively accelerated cash flow.

Bohui Shares released its Q1 earnings forecast on April 1, and the next day its stock price surged by 20%. In its announcement, Bohui Shares projected its net profit attributable to shareholders for Q1 to be between RMB 40 million and RMB 50 million, turning profitable year-over-year. During the reporting period, the company took measures to actively expand its market, optimize its product mix, and achieve stable and high production in Q1, with significant increases in output, sales, revenue, and net profit. Additionally, the new business segment became profitable, contributing a new source of profit growth for the company’s overall performance.

Dinglong Shares released its Q1 earnings forecast on March 26, and the next day its stock price rose over 17%. Dinglong Shares announced that it expects its net profit attributable to shareholders for Q1 to be between RMB 240 million and RMB 260 million, representing a year-over-year increase of 70.22%-84.41% and a quarter-over-quarter increase of 19.53%-29.49%. The company’s business continues to show strong momentum, with steady growth in semiconductor materials revenue. Continuous optimization of the product mix and deepening lean operational management have led to steadily improving operational efficiency, further enhancing the company’s overall profitability.

Fang Chen, an analyst at Shanghai Securities, published a research note on April 1 stating that Dinglong Shares, as a leading domestic platform company for innovative materials addressing critical bottlenecks, is based on CMP polishing pads and continues to expand and enrich its business layout. This includes CMP polishing pads, CMP polishing fluids and cleaning solutions, display materials, advanced semiconductor packaging, and high-end wafer photoresists, driving growth in the company’s revenue and profit levels. Meanwhile, the company remains committed to increasing the level of upstream supply chain autonomy to ensure the core competitiveness of its products. The acquisition of Haofei New Materials, entering the lithium battery materials industry, is expected to significantly boost the company’s performance.

Tianshan Aluminum released its earnings forecast on March 29, and the next day its stock price hit the daily trading limit. Tianshan Aluminum announced that it expects its net profit attributable to shareholders for Q1 to be RMB 2.2 billion, representing a year-over-year increase of 107.92%. The primary reasons for the company’s performance growth are: partial capacity commissioning of the 1.4 million-ton green and low-carbon efficiency improvement project for electrolytic aluminum, with electrolytic aluminum production and sales volume growing by approximately 10% year-over-year; simultaneously, the sales price of electrolytic aluminum products increased by about 17% year-over-year, while production costs were effectively controlled, showing a year-over-year decrease. Both volume and price contributed synergistically.

Shandong Head Co., Ltd. released its earnings forecast on March 27, and the stock price surged by the daily limit the next day. According to the announcement, Shandong Head Co., Ltd. expects its net profit attributable to shareholders for the first quarter to range between RMB 90.3386 million and RMB 99.3725 million, representing a year-on-year increase of 100% to 120%. During the reporting period, the company has continuously intensified its efforts to expand both domestic and international markets and optimized its product mix. Sales of high value-added products such as plant-based hollow capsules have achieved significant growth compared with the same period last year. Additionally, the improvement in capacity utilization effectively reduced fixed asset depreciation and other amortization expenses, resulting in a substantial increase in the company’s net profit for the first quarter of 2026 compared with the same period last year.



Source link

Visited 1 times, 1 visit(s) today

Related Article

Got $500? This Fintech Stock Could Reward Patient Long-Term Investors.

You don’t have to put much into the stock market to start building wealth. A single $500 investment in a stock that has promising long-term growth prospects is capable of growing into a much larger sum over time, thanks to the power of compounding. Fintech stock Robinhood Markets (HOOD 1.71%) is one potential example of

The S&P 500 Is Down 4% in 2026. Here Is What Long-Term Investors Should Do Now.

It’s been a turbulent year for the stock market. The S&P 500 (SNPINDEX: ^GSPC) index has been hurt by worsening sentiment. It could be from the Middle East conflict, the acceptance of higher interest rates for longer, or general uncertainty. As of April 1, the widely followed benchmark is down 4% in 2026. This is

If You Think the End of the Iran War Will Lead to a “Trump Bump” on Wall Street, You’ll Be Sorely Disappointed

During Donald Trump’s first term in office (Jan. 20, 2017 – Jan. 20, 2021), he oversaw some of the highest annualized stock market returns of any president since the late 1890s. When his term concluded, the ageless Dow Jones Industrial Average (DJINDICES: ^DJI), broad-based S&P 500 (SNPINDEX: ^GSPC), and tech-dependent Nasdaq Composite (NASDAQINDEX: ^IXIC) gained

2 AI Stocks That Survived the March Sell-Off — and Look Stronger Because of It

The March sell-off hit even the hottest areas of technology. However, not every tech stock was down for the month, and one pair of stocks in particular stood out as not only surviving the sell-off but coming out looking even stronger. That pair is Arm Holdings (NASDAQ: ARM) and Advanced Micro Devices (NASDAQ: AMD), whose

If a Stock Market Crash Is Coming, These 3 Investing Moves Are Crucial Right Now

Stock prices have been sliding, and major indexes recently reached new lows for the year. The S&P 500 (SNPINDEX: ^GSPC) is down by nearly 6% from its peak, as of this writing, with the Nasdaq Composite (NASDAQINDEX: ^IXIC) falling by around 9% after recently entering correction territory. This doesn’t constitute a market crash, and the

In a Volatile Market, This Is the Smartest Dividend Stock to Buy With $120

The stock market has offered investors a rollercoaster ride over the past several weeks, shifting between gains and losses. Expectations of rising volatility have been high, as we can see through recent peaks in the VIX — and when this volatility index rises, it also suggests investors are growing more fearful. Concerns emerged late last

Jim Cramer Highlights RH’s “Suboptimal Situation”

RH (NYSE:RH) is among the stocks in focus, as Jim Cramer analyzed the broader market impact of the recent AI data center rally. Cramer showed a pessimistic sentiment toward the stock, as he said: Finally, because we need rate cuts to sustain this rally, I would’ve liked to see the home builders rally, but other

“I Think They’ll Have a Great 2026 and 2027”

Palantir Technologies Inc. (NASDAQ:PLTR) is among the stocks in focus, as Jim Cramer analyzed the broader market impact of the recent AI data center rally. When a caller asked about the stock during the episode, Cramer said: Well, you know, Palantir right now, I have to tell you, here’s what’s going on with Palantir… It

You Wouldn’t Have Lost Money)

We all know how costly healthcare is, and that it’s big business, making plenty of people wealthy. You might be wondering, then, how you’d have done if you’d invested in some healthcare companies in years past. Here’s how you would have done if you’d plunked $100 in shares of CVS Health (NYSE: CVS) five years

If Microsoft Get This One Thing Right, the Stock Could Explode

Microsoft (MSFT +1.01%) was an early winner in the AI boom. Its partnership with OpenAI put it in the pole position after ChatGPT launched in late 2022. However, more than three years later, Microsoft is looking like a laggard in AI. Copilot, its AI assistant, has received broad criticism for its high price tag, relatively

The Best High-Yield Financial Stock to Invest $1,000 in Right Now

Tensions are running high on Wall Street today. Consumers were already tightening their budgets even before the geopolitical conflict in the Middle East upended global energy markets. Fears of a recession, perhaps on a global scale, are well-founded. If you are looking for reliable high-yield dividend stocks in this environment, you need to err on

Forget short-term pain! 2 FTSE 100 shares to consider for long-term gain

Image source: Getty Images Aside from the appalling human cost, the Iran war has created significant challenges for many top FTSE 100 shares. Rocketing energy costs, surging inflation, rising interest rates, and cooler economic growth could all scupper corporate earnings. No wonder the index has dropped 5.6% over the last month, then. Yet the Footsie’s

an extraordinary chance to build a £1m Stocks and Shares ISA?

Image source: Getty Images Stock market corrections hand smart British investors a rare opportunity to propel their Stocks and Shares ISAs to new heights. And it looks like we might be in the early innings of another widespread sell-off. The FTSE 250 fell close to 12% in the last month before making a slight recovery.

The Second-Best Performing Vanguard ETF Over the Last Decade Is Issuing a 5-For-1 Stock Split. Here’s Why It’s a Screaming Buy in April.

Investment management firm Vanguard has announced share splits for five of its most popular equity index exchange-traded funds (ETFs) — including the Vanguard Mega Cap Growth ETF (MGK +0.03%). Effective April 21, the ETF will be undergoing a 5-for-1 stock split “to widen availability for investors by keeping share prices within accessible trading ranges.” The

0
Would love your thoughts, please comment.x
()
x